alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
QuickLinks
 -- Click here to rapidly navigate through this document











 



 
 

Exhibit 10.49    
    


         

  


February 22,
2008 


Conrad
J. Hunter

c/o iPCS, Inc.

1901 N. Roselle Road

Schaumburg, IL 60195 


Dear
Mr. Hunter: 


        Reference
is made to the Employment Agreement, dated as of July 17, 2007 (the "Employment Agreement"), between you and iPCS Wireless, Inc. Capitalized terms used herein but
not defined herein shall have the meanings set forth in the Employment Agreement. 


        I
am pleased to inform you that the Compensation Committee of the Board of Directors took the following actions effective January 1, 2008: 



	•
	Increased
your Incentive Bonus under the Incentive Bonus Plan at the target level of performance to 65% of your Annual Base Salary.



	•
	Amended
and restated in their entirety clauses (a) and (b) of paragraph 1 of Exhibit A to the
Employment Agreement to read as follows: 



"(a)    a
lump sum payment equal to 200% of Executive's Annual Base Salary; 


(b)    continuation
of health benefits for Executive and Executive's qualified beneficiaries for the period beginning on the Termination Date and ending on the 24-month
anniversary of the Termination Date at a cost which is no greater than is charged to active employees of the Company and their dependents, which continuing health benefits shall be provided only if
Executive and Executive's qualified beneficiaries, as applicable, make a timely and proper election to be covered under COBRA;" 





        This
constitutes an amendment of your Employment Agreement. Please acknowledge this amendment by countersigning below. 



	

 	

 	

Very truly yours,
	

 	

 	
iPCS, Inc.
	

 	

 	

By:	

/s/ Edmund L. Quatmann, Jr.

	 	 	Name:  Edmund L. Quatmann, Jr.
	 	 	Title:  Vice President and General Counsel
	

AGREED AND ACKNOWLEDGED

this 22nd day of February, 2008	

 	

 
	

By:	

/s/ Conrad J. Hunter
	

 	

 













QuickLinks



Exhibit 10.49
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [File No. 500-1]

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Poseidis, Inc. (“Poseidis”) because it has not filed a periodic report since its 10-QSB/A for the quarterly period ended May 31, 2006, filed on November 21, 2007.

The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of Poseidis.

Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in Poseidis securities is suspended for the period from 9:30 a.m. EDT on April 14, 2009, through 11:59 p.m. EDT on April 27, 2009.

By the Commission.

Elizabeth M. Murphy,

Secretary.

[FR Doc. E9-8829 Filed 4-14-09; 4:15 pm]

BILLING CODE 8010-01-P
SIERRA HEALTH SERVICES, INC. AND SUBSIDIARIES

                        COMPUTATION OF EARNINGS PER SHARE

                                   EXHIBIT 11
<TABLE>
<CAPTION>


                                                                   Three Months Ended                  Nine Months Ended
                                                             September         September        September         September
                                                                 1997              1996             1997              1996
                                                             -----------       -----------      -----------       --------


<S>                                                              <C>             <C>             <C>               <C>
NET INCOME................................................       $495,000        $4,067,000      $12,454,000       $24,442,000

EARNINGS PER COMMON SHARE.................................           $.03              $.23             $.69             $1.38

Weighted Average Common Shares
 Outstanding..............................................     18,075,000        17,775,000       17,965,000        17,703,000



PRIMARY EARNINGS PER COMMON
 SHARE AND COMMON SHARE
 EQUIVALENT...............................................           $.03              $.23             $.68             $1.35

Weighted Average Common and Common
 Equivalent Shares Outstanding............................     18,387,000        18,154,000       18,233,000        18,167,000

FULLY DILUTED EARNINGS
 PER COMMON AND COMMON
 SHARE EQUIVALENT.........................................           $.03              $.22             $.68             $1.34

Weighted Average Common and Common
 Equivalent Shares Outstanding Assuming
 Full Dilution............................................     18,444,000        18,260,000       18,389,000        18,224,000
</TABLE>


Note:     Common Equivalent Shares represent the incremental effect of
          outstanding stockoptions and stock appreciation rights.




<PAGE>
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2715 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2715

   To extend the temporary suspension of duty on chloromethylbenzene.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To extend the temporary suspension of duty on chloromethylbenzene.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CHLOROMETHYLBENZENE.

    (a) In General.--Heading 9902.22.18 of the Harmonized Tariff 
Schedule of the United States (relating to chloromethylbenzene) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
John SCHENONE, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-832

District Court of Appeal of Florida, Fifth District.

Decision filed December 12, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
# ^*i S

\l^ r80 0 Independenc

e Ave. , S.W . U.S . Departmen t Washington , D.c . 2059 1 o f Transportatio n Federa l Aviatio n Administratio n VI A TELECOPIE R Augus t 28 , 200 9 WilliamElder , Esq . Hogan & Hartso n 7 ^ Columbi aSquar e " - ^ 55 5 ThirteenthSt. , N.W . ; _ 5 Washington , D.C . 2000 4 ^^5 ^ (fa x no . 202-637-5910 )

— 1 - o Dary l M . Williams , Esq . 3 S H Valle y Aviatio n Service s -:= • § Baird , William s & Greer , LL P"" ' 622 5 N . 24*

^ Street , Suit e 12 5 Phoenix , A Z8501 6 (fa x no . 602-271-9308 ) Re : Valle y Aviatio n Service s v . City o f Glendale , FA A Docke t

No . 16-09-0 6 Dea r Mr . Elde r

an dMr . Williams : Th e Federa l Aviatio n Administratio n ("FAA" ) receive dth e City o f Glendale' s reques t

for a30

- da y extensio n o f

tim e i n whic ht o fil e arespons e t o th e complaint . Base do n counsel' s representatio n that

counse l for

th e Complainan t

doe s not oppos e thi s request , th e FA A hereb y grant s th e reques t

for a n extensio n unti l Septembe r 17 , 2009 . I f yo u hav e an y questions , pleas e contac t me . yo u for you r attei^tic n t o thi s matter . I/VVAX? ! ElizabethJ . Hea d,yEsq . Airport s La w Br^ch , AGC-61 0 Offic e o f th e Chie f Counse l Federal Aviatio n Administratio n 80 0 Independenc e Ave. , S.W. , Washington , D.C . 2059 1 Elizabeth.Head@faa.go v (202)267-3211(0 )Cop y to : FAA Part 1 6 Airport

Proceeding s Docke t

(AGC-610 ) Airport Complianc e Divisio n Offic e o f Airport Complianc e an dFiel dOperation s ACO-lO O
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2720 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2720

 To suspend temporarily the duty on mixtures containing fluopyram and 
                            trifloxystrobin.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To suspend temporarily the duty on mixtures containing fluopyram and 
                            trifloxystrobin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES CONTAINING FLUOPYRAM AND TRIFLOXYSTROBIN.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Mixtures            Free         No change        No change        On or before 12/  ''.
                        containing N-{2-                                                   31/2015.......
                        [3-chloro-5-
                        (trifluoromethyl)-
                        2-
                        pyridinyl]ethyl}-
                        a,a,a-trifluoro-o-
                        toluamide
                        (fluopyram) (CAS
                        No. 658066-35-4)
                        and methyl (aE)-a-
                        (methoxyimino)-2-
                        [[[(E)-[1-[3-
                        (trifluoromethyl)
                        phenyl]ethylidene
                        ] amino]
                        oxy]methyl]benzen
                        eacetate
                        (trifloxystrobin)
                        (CAS No. 141517-
                        21-7) including
                        application
                        adjuvants
                        (provided for in
                        subheading
                        3808.91.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Federal Register Volume 74, Number 74 (Monday, April 20, 2009)]
[Notices]
[Page 18004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8518]

-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Disaster Declaration 11686 and 11687]

Indiana Disaster Number IN-00029

AGENCY: U.S. Small Business Administration.

ACTION: Amendment 1.

-----------------------------------------------------------------------

SUMMARY: This is an amendment of the Presidential declaration of a 
major disaster for Public Assistance Only for the State of Indiana 
(FEMA-1828-DR), dated 03/05/2009.
    Incident: Severe Winter Storm.
    Incident Period: 01/26/2009 through 01/28/2009.
    Effective Date: 04/06/2009.
    Physical Loan Application Deadline Date: 05/04/2009.
    Economic Injury (EIDL) Loan Application Deadline Date: 12/05/2009.

ADDRESSES: Submit completed loan applications to: U.S. Small Business 
Administration, Processing and Disbursement Center, 14925 Kingsport 
Road, Fort Worth, TX 76155.

FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster 
Assistance, U.S. Small Business Administration, 409 3rd Street, SW., 
Suite 6050, Washington, DC 20416.

SUPPLEMENTARY INFORMATION: The notice of the President's major disaster 
declaration for Private Non-Profit organizations in the State of 
Indiana, dated 03/05/2009, is hereby amended to include the following 
areas as adversely affected by the disaster.

Primary Counties:
    Jennings, Lawrence, Ohio, Posey, Ripley, Scott.

    All other information in the original declaration remains 
unchanged.

(Catalog of Federal Domestic Assistance Numbers 59002 and 59008)
James E. Rivera,
Acting Associate Administrator for Disaster Assistance.
[FR Doc. E9-8518 Filed 4-17-09; 8:45 am]
BILLING CODE 8025-01-P
```
<PAGE>

                                                                    EXHIBIT 32.1

                                 CERTIFICATION

     Pursuant to 18 U.S.C. sec. 1350, the undersigned officer of Novelis Inc.
(the "Company"), hereby certifies that the Company's Annual Report on Form 10-K
for the year ended December 31, 2004 (the "Report") fully complies with the
requirements of Section 13(a) or Section 15(d), as applicable, of the Securities
Exchange Act of 1934, as amended, and that the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.

Date: March 23, 2005
                                          /s/ Brian W. Sturgell
                                          --------------------------------------
                                          Brian W. Sturgell
                                          Chief Executive Officer
                                          (Principal Executive Officer)

     The foregoing certification is being furnished solely pursuant to 18 U.S.C.
Section 1350 and is not being filed as part of this report.
EXHIBIT
13.2














CERTIFICATION
OF ARTHUR LANG


PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED


PURSUANT
TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002












Exhibit
13.2














CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002








In
connection with the Annual Report of Amera Resources Corporation (the ACompany@) on Form
20-F/A, Amendment No. 1, for the year ending December 31, 2006, as filed with
the Securities and Exchange Commission on the date hereof (the AReport@), I, Arthur
Lang, Chief Financial Officer and Director of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





A signed
original of this written statement has been provided to the Company and will be
retained by the Company and furnished to the SEC or its staff upon
request.








Dated: 
June 6, 2008








/s/ Arthur
Lang


Arthur
Lang,


Chief
Financial Officer and Director
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2647 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2647

To extend and modify the temporary reduction of duty on certain bicycle 
                                brakes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Ms. Klobuchar introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend and modify the temporary reduction of duty on certain bicycle 
                                brakes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN BICYCLE BRAKES.

    (a) In General.--Heading 9902.24.71 of the Harmonized Tariff 
Schedule of the United States (relating to brakes designed for bicycles 
(other than drum brakes, caliper and cantilever brakes, and coaster 
brakes) and parts thereof) is amended--
            (1) by striking ``6.3%'' in column 1 general rate of duty 
        column and inserting ``Free''; and
            (2) by striking the date in the effective period column and 
        inserting ``12/31/2015''.
    (b) Effective Date.--The amendments made by subsection (a) apply 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 282 Introduced in Senate (IS)]

112th CONGRESS
  1st Session
                                 S. 282

                      To rescind unused earmarks.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            February 3, 2011

Mr. Coburn (for himself and Mr. Begich) introduced the following bill; 
  which was read twice and referred to the Committee on Appropriations

_______________________________________________________________________

                                 A BILL

 
                      To rescind unused earmarks.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Orphan Earmarks Act''.

SEC. 2. UNUSED EARMARKS.

    (a) Definition.--In this section, the term ``earmark'' means the 
following:
            (1) A congressionally directed spending item, as defined in 
        Rule XLIV of the Standing Rules of the Senate.
            (2) A congressional earmark, as defined for purposes of 
        Rule XXI of the Rules of the House of Representatives.
    (b) Rescission.--Any earmark of funds provided for any Federal 
agency with more than 90 percent of the appropriated amount remaining 
available for obligation at the end of the 9th fiscal year following 
the fiscal year in which the earmark was made available is rescinded 
effective at the end of that 9th fiscal year, except that the agency 
head may delay any such rescission if the agency head determines that 
an additional obligation of the earmark is likely to occur during the 
following 12-month period.
    (c) Identification and Report.--
            (1) Agency identification.--Each Federal agency shall 
        identify and report every project that is an earmark with an 
        unobligated balance at the end of each fiscal year to the 
        Director of OMB.
            (2) Annual report.--The Director of OMB shall submit to 
        Congress and publically post on the Web site of OMB an annual 
        report that includes--
                    (A) a listing and accounting for earmarks with 
                unobligated balances summarized by agency including the 
                amount of the original earmark, amount of the 
                unobligated balance, and the year when the funding 
                expires, if applicable;
                    (B) the number of rescissions resulting from this 
                section and the annual savings resulting from this 
                section for the previous fiscal year; and
                    (C) a listing and accounting for earmarks provided 
                for Federal agencies scheduled to be rescinded at the 
                end of the current fiscal year.
                                 <all>
```
**Exhibit 23**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation byreference in Registration Statements (No. 333-133656) on Form S-3 and (No. 333-123641) on Form S-8 of CardioVascular BioTherapeutics, Inc. (the “Company”) of our report dated April 12, 2007, which includes an emphasis paragraphrelating to an uncertainty as to the Company’s ability to continue as a going concern, relating to our audit of the financial statements which appear in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-Kof CardioVascular BioTherapeutics, Inc. for the year ended December 31, 2006. 

/s/ SINGER LEWAK GREENBAUM & GOLDSTEIN LLP 

Los Angeles, California 

April 12, 2007
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2677 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2677

    To suspend temporarily the rate of duty on 1-benzyl-4-phenyl-4-
              piperidine carboxylic acid ethyl ester HCl.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the rate of duty on 1-benzyl-4-phenyl-4-
              piperidine carboxylic acid ethyl ester HCl.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 1-BENZYL-4-PHENYL-4-PIPERIDINE CARBOXYLIC ACID ETHYL ESTER 
              HCL.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        1-Benzyl-4-phenyl-  Free            No change      No change      On or before     ''.
                          4-piperidine                                                      12/31/2015
                          carboxylic acid
                          ethyl ester HCl
                          (CAS No. 72216-57-
                          0) (provided for
                          in subheading
                          2933.32.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```